sorafenib has been researched along with gadoxetic acid disodium in 3 studies
| Studies (sorafenib) | Trials (sorafenib) | Recent Studies (post-2010) (sorafenib) | Studies (gadoxetic acid disodium) | Trials (gadoxetic acid disodium) | Recent Studies (post-2010) (gadoxetic acid disodium) |
|---|---|---|---|---|---|
| 6,520 | 730 | 5,251 | 1,720 | 95 | 1,432 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Kudo, M | 1 |
| Cai, H; Dong, Y; Dong, Z; Feng, ST; Huang, K; Huang, M; Jia, Y; Li, ZP; Liao, B; Luo, Y; Xu, L; Zhou, X | 1 |
| Bargellini, I; Berg, T; Gasbarrini, A; Iezzi, R; Klümpen, HJ; Malfertheiner, P; Öcal, O; Pech, M; Peynircioglu, B; Ricke, J; Rössler, D; Sangro, B; Schulz, C; Schütte, K; Seidensticker, M; van Delden, O | 1 |
1 trial(s) available for sorafenib and gadoxetic acid disodium
| Article | Year |
|---|---|
Gadoxetic acid uptake as a molecular imaging biomarker for sorafenib resistance in patients with hepatocellular carcinoma: a post hoc analysis of the SORAMIC trial.
Topics: Biomarkers; Carcinoma, Hepatocellular; Catenins; Contrast Media; Gadolinium DTPA; Humans; Liver Neoplasms; Magnetic Resonance Imaging; Molecular Imaging; Retrospective Studies; Sorafenib | 2022 |
2 other study(ies) available for sorafenib and gadoxetic acid disodium
| Article | Year |
|---|---|
The 2008 Okuda lecture: Management of hepatocellular carcinoma: from surveillance to molecular targeted therapy.
Topics: Algorithms; alpha-Fetoproteins; Antineoplastic Agents; Benzenesulfonates; Biomarkers; Biomarkers, Tumor; Carcinoma, Hepatocellular; Contrast Media; Early Detection of Cancer; Gadolinium DTPA; Humans; Infusion Pumps; Japan; Liver Neoplasms; Magnetic Resonance Imaging; Mass Screening; Neoplasm Staging; Niacinamide; Phenylurea Compounds; Population Surveillance; Protein Precursors; Prothrombin; Pyridines; Sensitivity and Specificity; Sorafenib; Survival Rate | 2010 |
Prediction of sorafenib treatment-related gene expression for hepatocellular carcinoma: preoperative MRI and histopathological correlation.
Topics: Adult; Aged; Antineoplastic Agents; Carcinoma, Hepatocellular; Contrast Media; Feasibility Studies; Female; Gadolinium DTPA; Humans; Image Enhancement; Liver Neoplasms; Magnetic Resonance Imaging; Male; Middle Aged; Preoperative Period; Proto-Oncogene Proteins B-raf; Proto-Oncogene Proteins c-raf; Retrospective Studies; Risk Factors; Sorafenib; Vascular Endothelial Growth Factor Receptor-2; Vascular Endothelial Growth Factor Receptor-3 | 2019 |